TTM
$4.24B
YoY change
+14.7%
5Y CAGR
+13.9%
Peak year (2017)
$4.06B
Cumulative net income
$39.48B
Net Income history chart for CME Group (CME) from 2000 to 2025
Latest: $4.04B
Net Income growth chart for CME Group (CME) from 2000 to 2025
Latest: +14.7%
Net Income history table for CME Group (CME) from 2000 to 2025
| 2025 | $4.04B | +14.7% | +$518.60M | ||
| 2024 | $3.53B | +9.3% | +$299.60M | ||
| 2023 | $3.23B | +19.9% | +$535.20M | ||
| 2022 | $2.69B | +2.1% | +$54.60M | ||
| 2021 | $2.64B | +25.2% | +$531.20M | ||
| 2020 | $2.11B | -0.5% | −$11.30M | ||
| 2019 | $2.12B | +7.9% | +$154.30M | ||
| 2018 | $1.96B | -51.7% | −$2.10B | ||
| 2017 | $4.06B | +164.9% | +$2.53B | ||
| 2016 | $1.53B | +23.0% | +$287.10M | ||
| 2015 | $1.25B | +10.6% | +$119.90M | ||
| 2014 | $1.13B | +15.4% | +$150.30M | ||
| 2013 | $976.80M | +9.0% | +$80.50M | ||
| 2012 | $896.30M | -50.5% | −$916.00M | ||
| 2011 | $1.81B | +90.5% | +$860.90M | ||
| 2010 | $951.40M | +15.2% | +$125.60M | ||
| 2009 | $825.80M | +15.4% | +$110.31M | ||
| 2008 | $715.49M | +8.6% | +$56.95M | ||
| 2007 | $658.53M | +61.7% | +$251.19M | ||
| 2006 | $407.35M | +32.7% | +$100.49M | ||
| 2005 | $306.86M | +39.8% | +$87.30M | ||
| 2004 | $219.56M | +79.8% | +$97.42M | ||
| 2003 | $122.13M | +29.8% | +$28.07M | ||
| 2002 | $94.07M | +37.7% | +$25.77M | ||
| 2001 | $68.30M | -1255.9% | +$74.21M | ||
| 2000 | −$5.91M | — | — |
- 2025$4.04B+14.7%
- 2024$3.53B+9.3%
- 2023$3.23B+19.9%
- 2022$2.69B+2.1%
- 2021$2.64B+25.2%
- 2020$2.11B-0.5%
- 2019$2.12B+7.9%
- 2018$1.96B-51.7%
- 2017$4.06B+164.9%
- 2016$1.53B+23.0%
- 2015$1.25B+10.6%
- 2014$1.13B+15.4%
- 2013$976.80M+9.0%
- 2012$896.30M-50.5%
- 2011$1.81B+90.5%
- 2010$951.40M+15.2%
- 2009$825.80M+15.4%
- 2008$715.49M+8.6%
- 2007$658.53M+61.7%
- 2006$407.35M+32.7%
- 2005$306.86M+39.8%
- 2004$219.56M+79.8%
- 2003$122.13M+29.8%
- 2002$94.07M+37.7%
- 2001$68.30M-1255.9%
- 2000−$5.91M—
Net Income values are taken from CME Group's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Net Income at CME Group (CME)
According to CME Group's latest reported financial statements, the company's current net income (TTM) is $4.24B. Net income is the bottom-line profit after all expenses — cost of goods sold, operating expenses, interest, and taxes — are subtracted from revenue. It is the figure used to compute earnings per share (EPS) and is the residual available to shareholders.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, CME Group (CME) reported net income of $4.04B – grew 14.7% year-over-year.
Through 2020–2025 (5 years), CME Group net income delivered a +13.9% annualised rate; sustaining 5 straight years of year-over-year growth.
The record annual net income stands at $4.06B, reached in 2017; the historical low of −$5.91M was recorded in 2000.
CME Group Net Income by Year
CME Group Net Income 2025: $4.04B
CME Group net income in 2025 was $4.04B, grew 14.7% from 2024.
CME Group Net Income 2024: $3.53B
2024's net income for CME Group came in at $3.53B, grew 9.3% from 2023.
CME Group Net Income 2023: $3.23B
CME Group posted net income of $3.23B in 2023, grew 19.9% from 2022.
CME Group Net Income 2022: $2.69B
In 2022, CME Group reported net income of $2.69B, edged up 2.1% from 2021.
CME Group Net Income 2021: $2.64B
CME Group net income in 2021 was $2.64B.
See more financial history for CME Group (CME).
Sector peers by Net Income
Financial Services peers of CME Group (CME), ranked by their latest net income
| $66.97B | |
| $57.05B | |
| $30.51B | |
| $21.34B | |
| $20.06B | |
| $17.18B | |
| $16.86B | |
| $14.97B |
- $66.97B
- $57.05B
- $30.51B
- $21.34B
- $20.06B
- $17.18B
- $16.86B
- $14.97B
Frequently asked questions
CME Group (CME) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation